Alexander Hsu‐Wilbraham
Research Subjects
Research Interests
Alexander Hsu‐Wilbraham has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Asli Atici
Guerin Children’s at Cedars‐Sinai Medical Center
1 shared publication- Asli D. Yildirim
Guerin Children’s at Cedars‐Sinai Medical Center
1 shared publication - Debbie Moreira
Guerin Children’s at Cedars‐Sinai Medical Center
1 shared publication - Emily Aubuchon
Department of Pediatrics, Cedars-Sinai Guerin Children’s (A.E.A., P.K.J., T.T.C., B.L.R., E.A.A., M.E.L., A.C.G., Y.L., S.C., T.R.C., M.A., M.N.R.), Cedars‑Sinai Health Sciences University, Los Angeles, CA
1 shared publication - Kenichi Shimada
Department of Pediatrics, Division of Infectious Diseases and Immunology, Guerin Children’s at Cedars-Sinai Medical Center
1 shared publication - Magali Noval Rivas
Department of Pediatrics, Cedars-Sinai Guerin Children’s, Cedars-Sinai Health Sciences University, Los Angeles, CA, USA
1 shared publication
Latest Publications
- Open Access
- 3 June 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (11) , e040687
Interleukin‐1 Signaling on Vascular Smooth Muscle Cells Accelerates Atherosclerosis in a Murine Model of Kawasaki Disease
Background: We previously showed that Lactobacillus casei cell wall extract‐induced Kawasaki disease (KD) vasculitis significantly accelerates atherosclerosis in hypercholesterolemic mice on high‐fat diet. Here, we investigated the contribution of IL‐1 (interleukin‐1) signaling on vascular smooth muscle cells in this model. Methods: Tamoxifen‐inducible vascular smooth muscle cell‐specific IL‐1 receptor ( Il1r1) knockout ( SMC Δ/Δ ) mice and Il1r1SMC WT/WT [wildtype/wildtype] littermate controls, all on ApoE −/− background, were injected with either PBS or Lactobacillus casei cell wall extract. Two weeks later, mice were fed a tamoxifen diet for 2 weeks to induce Il1r1 deletion on vascular smooth muscle cells before being exposed to 8 weeks of Western diet to promote atherosclerosis. Results: KD vasculitis led to a significant acceleration of atherosclerosis. Il1r1SMC Δ/Δ mice had significantly diminished atherosclerotic plaque size, macrophage infiltration, and necrotic core formation in the aortic root, as well as diminished lipid accumulation in the aorta en face compared with control mice, despite similar serum cholesterol levels. Il1r1SMC Δ/Δ mice also had significantly diminished expression of endothelial adhesion molecules VCAM‐1 (vascular cell adhesion molecule 1) and ICAM‐1 (intercellular adhesion molecule 1) in the lesion area, as well as reduced serum MCP‐1 (monocyte chemotaxis protein‐1) levels compared with Il1r1SMC WT/WT control mice. Monocyte and macrophage recruitment was significantly reduced in the Il1r1 SMC Δ/Δ group compared with the Il1r1 SMC WT/WT group. Conclusions: Our results suggest an important pathophysiologic link between IL‐1 signaling on vascular smooth muscle cells and subsequent acceleration of atherosclerosis in hypercholesterolemic mice following KD vasculitis. Thus, further studies are warranted to investigate the role of IL‐1 signaling not only in acute KD but also in the subsequent vascular remodeling and long‐term complications of KD vasculitis, including accelerated atherosclerosis.
- 3 June 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (11) , e040687
Open AccessInterleukin‐1 Signaling on Vascular Smooth Muscle Cells Accelerates Atherosclerosis in a Murine Model of Kawasaki Disease
Background: We previously showed that Lactobacillus casei cell wall extract‐induced Kawasaki disease (KD) vasculitis significantly accelerates atherosclerosis in hypercholesterolemic mice on high‐fat diet. Here, we investigated the contribution of IL‐1 (interleukin‐1) signaling on vascular smooth muscle cells in this model. Methods: Tamoxifen‐inducible vascular smooth muscle cell‐specific IL‐1 receptor ( Il1r1) knockout ( SMC Δ/Δ ) mice and Il1r1SMC WT/WT [wildtype/wildtype] littermate controls, all on ApoE −/− background, were injected with either PBS or Lactobacillus casei cell wall extract. Two weeks later, mice were fed a tamoxifen diet for 2 weeks to induce Il1r1 deletion on vascular smooth muscle cells before being exposed to 8 weeks of Western diet to promote atherosclerosis. Results: KD vasculitis led to a significant acceleration of atherosclerosis. Il1r1SMC Δ/Δ mice had significantly diminished atherosclerotic plaque size, macrophage infiltration, and necrotic core formation in the aortic root, as well as diminished lipid accumulation in the aorta en face compared with control mice, despite similar serum cholesterol levels. Il1r1SMC Δ/Δ mice also had significantly diminished expression of endothelial adhesion molecules VCAM‐1 (vascular cell adhesion molecule 1) and ICAM‐1 (intercellular adhesion molecule 1) in the lesion area, as well as reduced serum MCP‐1 (monocyte chemotaxis protein‐1) levels compared with Il1r1SMC WT/WT control mice. Monocyte and macrophage recruitment was significantly reduced in the Il1r1 SMC Δ/Δ group compared with the Il1r1 SMC WT/WT group. Conclusions: Our results suggest an important pathophysiologic link between IL‐1 signaling on vascular smooth muscle cells and subsequent acceleration of atherosclerosis in hypercholesterolemic mice following KD vasculitis. Thus, further studies are warranted to investigate the role of IL‐1 signaling not only in acute KD but also in the subsequent vascular remodeling and long‐term complications of KD vasculitis, including accelerated atherosclerosis.